Mode
Text Size
Log in / Sign up

Digital phenotyping enables real-time mental health monitoring and risk prediction in people with diabetesDigital Tools May Help Track Mental Health in People with Diabetes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that digital phenotyping offers real-time monitoring potential but currently lacks external validation and intervention data.

This scoping review synthesizes 10 studies to map the application pathways of digital phenotyping for monitoring and predicting mental health in people with diabetes. Digital phenotyping encompasses various data streams, including continuous glucose monitoring (CGM), passive smartphone sensing, voice analysis, and ecological momentary assessment (EMA). These technologies allow for real-time monitoring of mental health indicators.

Regarding risk prediction, the authors note that while machine learning methods are widely utilized, most models are constructed at the group level. The review highlights a significant gap in personalized medicine, noting that few models utilize n-of-1 analysis or subgroup prediction. Furthermore, the authors report that external validation of these models is generally lacking. No intervention studies were identified in the included literature.

Clinical application is currently limited by the lack of individualized risk prediction and the absence of multi-center external validation. While the technology offers potential for real-time monitoring, the evidence is currently exploratory. Future research is needed to develop closed-loop monitoring-intervention designs to improve clinical utility.

How this fits prior evidence

This scoping review addresses a gap in the management of mental health in patients with diabetes by exploring digital phenotyping technologies. While previous coverage identified a link between adolescent idiopathic scoliosis and anxiety and depression, and noted the risk of gestational diabetes from certain psychotropic medications, this review specifically focuses on the technological monitoring of mental health in the diabetic population. It does not provide data on the efficacy of specific treatments like electrical stimulation or MBSR for anxiety and depression.

Researchers reviewed 10 studies to see how digital phenotyping can monitor mental health in people with diabetes. Digital phenotyping includes using tools like continuous glucose monitors, smartphone sensors, voice analysis, and real-time surveys to gather data. These methods allow for real-time monitoring of mental health indicators like anxiety and depression.

While the technology shows promise, the current research is limited. Most of the models used to predict risks were built for large groups rather than for individuals. Additionally, many of the models lacked external validation, which means they have not been tested in different settings to ensure they work consistently for everyone.

Because this is a scoping review of a small number of studies, the findings are early and not yet ready to change daily medical practice. The research is still in the exploratory stage. It highlights the potential for real-time monitoring, but more large-scale testing is needed to ensure these tools are reliable for individual patients.

What this means for you:
Digital tools show potential for tracking mental health in diabetes, but more research is needed to ensure accuracy.

Common questions

What is digital phenotyping and how does it help?

Digital phenotyping uses technology like continuous glucose monitors, smartphone sensors, voice analysis, and real-time surveys to gather data. In this study, these tools were used to monitor and predict mental health markers, such as anxiety and depression, in people living with diabetes.

Can these tools predict mental health issues for individuals?

Currently, most models used in the research were built for large groups rather than for individuals. The study found that very few models used individual-level analysis. More research is needed to create tools that can accurately predict risks for specific people.

Are these digital tools ready to use in clinics?

The evidence is currently limited because many models lacked external validation and no intervention studies were found. While the technology shows potential for real-time monitoring, it is still in the exploratory stage and requires more testing before it can be used as a standard clinical tool.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Diabetes frequently co-occurs with depression, anxiety, and diabetes-related distress, and psychological status directly influences glycaemic control and the risk of complications. Traditional mental health assessment relies on subjective scales. With the growth of digital health, digital phenotyping offers a new paradigm for real-time, objective mental health monitoring and prediction. However, the pathways through which these technologies perform monitoring and prediction remain unclear. This scoping review aimed to systematically map the application pathways of digital phenotyping for mental health monitoring and prediction in people with diabetes, and to use machine learning-assisted text mining to analyse the main research themes and hotspots, thereby informing the future development of individualised risk prediction models and monitoring systems. A scoping review search was conducted in six English databases (PubMed, Embase, CINAHL, Web of Science, Scopus, and the Cochrane Library) and four Chinese databases (CNKI, Wanfang, VIP, and China Biomedical Literature Database[CBM]), covering studies published from database inception to 10 September 2026. The search strategy was built around terms related to diabetes, digital phenotyping, and mental health. Machine learning-assisted literature mining was used to identify thematic patterns in the included studies. The study selection process and overall workflow followed the PRISMA extension for scoping reviews (PRISMA-ScR). A total of 2,968 records were retrieved. After screening, 10 studies were included. The evidence indicated that digital phenotyping mainly enables real-time monitoring of mental health in people with diabetes through signals such as continuous glucose monitoring (CGM), passive smartphone sensing, voice, and ecological momentary assessment (EMA). Machine learning methods were widely used for risk prediction modelling, but most studies built models at the group level, with only a few adopting n-of-1 analysis or subgroup prediction to achieve individualised risk prediction. External validation of models was generally lacking, and no intervention studies were identified. Preliminary evidence suggests that digital phenotyping has exploratory potential for mental health monitoring and prediction in people with diabetes, but research that genuinely achieves individualised risk prediction remains limited. Closed-loop monitoring-intervention design and multicentre external validation are the main directions for future research.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.